Neonatal thromboembolic emergencies

Seminars in Fetal and Neonatal Medicine

Volumn 11, Issue 3, 2006, Pages 198-206

  Thornburg, Courtney ^a   Pipe, Steven ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anticoagulation; Neonatal thrombosis; Thrombophilia

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTICOAGULANT AGENT; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; ARGATROBAN; DANAPAROID; ENOXAPARIN; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; HIRUDIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE SULFATE; PROTEIN C; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VITAMIN K GROUP; WARFARIN; XIMELAGATRAN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANTICOAGULANT THERAPY; ARTERY CATHETER; ARTERY THROMBOSIS; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CATHETER THROMBOSIS; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DIAGNOSTIC TEST; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG POTENCY; EMERGENCY CARE; ENVIRONMENTAL FACTOR; FIBRINOLYTIC THERAPY; FULMINATING PURPURA; GENETIC DISORDER; HEMOSTASIS; HUMAN; INCIDENCE; INDIVIDUALIZATION; INTRACARDIAC THROMBOSIS; INTRAVENOUS CATHETER; KIDNEY VEIN THROMBOSIS; LIMB DISEASE; MOTHER FETUS RELATIONSHIP; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; PORTAL VEIN THROMBOSIS; PRACTICE GUIDELINE; RISK FACTOR; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS; VEIN THROMBOSIS;

ANTICOAGULANTS; GUIDELINES; HEMOSTASIS; HEPARIN; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTENSIVE CARE, NEONATAL; PURPURA, SCHOENLEIN-HENOCH; RISK FACTORS; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOLYTIC THERAPY; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 33646076462     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2006.01.005     Document Type: Article

References (51)

1. Andrew M., Paes B., Milner R., Johnston M., Mitchell L., Tollefsen D.M., et al. Development of the human coagulation system in the healthy premature infant. Blood 72 (1988) 1651-1657
2. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 74 (1995) 415-425
3. Nowak-Gottl U., von Kries R., and Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 76 (1997) F163-F167
4. Schmidt B., and Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 96 (1995) 939-943
5. Andrew M., Paes B., and Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 12 (1990) 95-104
6. Andrew M., and Brooker L.A. Blood component therapy in neonatal hemostatic disorders. Transfus Med Rev 9 (1995) 231-250
7. Rajasekhar D., Kestin A.S., Bednarek F.J., Ellis P.A., Barnard M.R., and Michelson A.D. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 72 (1994) 957-963
8. Ries M., Klinge J., and Rauch R. Age-related reference values for activation markers of the coagulation and fibrinolytic systems in children. Thromb Res 85 (1997) 341-344
9. Ries M., Klinge J., Rauch R., Trusen B., Zenker M., Keuper H., et al. In vitro fibrinolysis after adding low doses of plasminogen activators and plasmin generation with and without oxidative inactivation of plasmin inhibitors in newborns and adults. J Pediatr Hematol Oncol 18 (1996) 346-351
10. Nowak-Gottl U., Kosch A., and Schlegel N. Neonatal thromboembolism. Semin Thromb Hemost 29 (2003) 227-234
11. Nowak-Gottl U., Duering C., Kempf-Bielack B., and Strater R. Thromboembolic diseases in neonates and children. Pathophysiol Haemost Thromb 33 (2003) 269-274
12. Heller C., and Nowak-Gottl U. Maternal thrombophilia and neonatal thrombosis. Best Pract Res Clin Haematol 16 (2003) 333-345
13. Manco-Johnson M.J., Grabowski E.F., Hellgreen M., Kemahli A.S., Massicotte M.P., Muntean W., et al. Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH). Thromb Haemost 88 (2002) 155-156
14. Monagle P., Chan A., Massicotte P., Chalmers E., and Michelson A.D. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 645S-687S
15. Andrew M.E., Monagle P., deVeber G., and Chan A.K. Thromboembolic disease and antithrombotic therapy in newborns. Hematology [Am Soc Hematol Educ Program] (2001) 358-374
16. Lynch J.K., Hirtz D.G., DeVeber G., and Nelson K.B. Report of the national institute of neurological disorders and stroke workshop on perinatal and childhood stroke. Pediatrics 109 (2002) 116-123
17. deVeber G., and Group CPISS. Canadian paediatric ischemic stroke registry: analysis of children with arterial ischemic stroke. Ann Neurol 48 (2000) 526a
18. Golomb M.R., MacGregor D.L., Domi T., Armstrong D.C., McCrindle B.W., Mayank S., et al. Presumed pre- or perinatal arterial ischemic stroke: risk factors and outcomes. Ann Neurol 50 (2001) 163-168
19. deVeber G., Monagle P., Chan A., MacGregor D., Curtis R., Lee S., et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 55 (1998) 1539-1543
20. Massicotte M.P., Dix D., Monagle P., Adams M., and Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian registry of venous thromboembolic complications. J Pediatr 133 (1998) 770-776
21. Kuhle S., Massicotte P., Chan A., and Mitchell L. A case series of 72 neonates with renal vein thrombosis. Data from the 1-800-NO-CLOTS Registry. Thromb Haemost 92 (2004) 729-733
22. Bromberg W.D., and Firlit C.F. Fibrinolytic therapy for renal vein thrombosis in the child. J Urol 143 (1990) 86-88
23. Greenway A., Massicotte M.P., and Monagle P. Neonatal thrombosis and its treatment. Blood Rev 18 (2004) 75-84
24. deVeber G., Andrew M., Adams C., Bjornson B., Booth F., Buckley D.J., et al. Cerebral sinovenous thrombosis in children. N Engl J Med 345 (2001) 417-423
25. Chan A.K., Deveber G., Monagle P., Brooker L.A., and Massicotte P.M. Venous thrombosis in children. J Thromb Haemost 1 (2003) 1443-1455
26. Berman Jr. W., Fripp R.R., Yabek S.M., Wernly J., and Corlew S. Great vein and right atrial thrombosis in critically ill infants and children with central venous lines. Chest 99 (1991) 963-967
27. Ross Jr. P., Ehrenkranz R., Kleinman C.S., and Seashore J.H. Thrombus associated with central venous catheters in infants and children. J Pediatr Surg 24 (1989) 253-256
28. Marlar R.A., and Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Hemost 16 (1990) 299-309
29. Dogan Y., Aygun D., Yilmaz Y., Kanra G., Secmeer G., Besbas N., et al. Severe protein S deficiency associated with heterozygous factor V Leiden mutation in a child with purpura fulminans. Pediatr Hematol Oncol 20 (2003) 1-5
30. Pipe S.W., Schmaier A.H., Nichols W.C., Ginsburg D., Bozynski M.E., and Castle V.P. Neonatal purpura fulminans in association with factor V R506Q mutation. J Pediatr 128 (1996) 706-709
31. Gobel U., von Voss H., Jurgens H., Petrich C., Pothmann R., Sprock I., et al. Efficiency of heparin in the treatment of newborn infants with respiratory distress syndrome and disseminated intravascular coagulation. Eur J Pediatr 133 (1980) 47-49
32. Andrew M., Massicotte-Nolan P., Mitchell L., and Cassidy K. Dysfunctional antithrombin III in sick premature infants. Pediatr Res 19 (1985) 237-239
33. von Kries R., Stannigel H., and Gobel U. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation. Eur J Pediatr 144 (1985) 191-194
34. Kreuz W.D., Schneider W., and Nowak-Gottl U. Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency-a feasibility pilot study. Eur J Pediatr 158 Suppl. 3 (1999) S187-S191
35. Gross S.J., Filston H.C., and Anderson J.C. Controlled study of treatment for disseminated intravascular coagulation in the neonate. J Pediatr 100 (1982) 445-448
36. Risch L., Fischer J., Herklotz R., and Huber A. Heparin-induced thrombocytopenia in paediatrics: clinical characteristics, therapy and outcomes. Intensive Care Med 30 (2004) 1615-1624
37. Male C., Johnston M., Sparling C., Brooker L., Andrew M., and Massicotte P. The influence of developmental haemostasis on the laboratory diagnosis and management of haemostatic disorders during infancy and childhood. Clin Lab Med 19 (1999) 39-69
38. Andrew M., Marzinotto V., Massicotte P., Blanchette V., Ginsberg J., Brill-Edwards P., et al. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res 35 (1994) 78-83
39. Weitz J.I. Low-molecular-weight heparins. N Engl J Med 337 (1997) 688-698
40. Massicotte P., Julian J.A., Marzinotto V., Gent M., Shields K., Chan A.K., et al. Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patients. Thromb Res 109 (2003) 93-99
41. Streif W., Goebel G., Chan A.K., and Massicotte M.P. Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. Arch Dis Child Fetal Neonatal Ed 88 (2003) F365-F370
42. Michaels L.A., Gurian M., Hegyi T., and Drachtman R.A. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics 114 (2004) 703-707
43. Streif W., Andrew M., Marzinotto V., Massicotte P., Chan A.K., Julian J.A., et al. Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood 94 (1999) 3007-3014
44. Rijken D.C., Otter M., Kuiper J., and van Berkel T.J. Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells. Thromb Res Suppl 10 (1990) 63-71
45. Manco-Johnson M.J., Grabowski E.F., Hellgreen M., Kemahli A.S., Massicotte M.P., Muntean W., et al. Recommendations for tPA thrombolysis in children. On behalf of the scientific subcommittee on perinatal and pediatric thrombosis of the scientific and standardization committee of the international society of thrombosis and haemostasis. Thromb Haemost 88 (2002) 157-158
46. Weiner G.M., Castle V.P., DiPietro M.A., and Faix R.G. Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator. J Pediatr 133 (1998) 133-136
47. Zenz W., Arlt F., Sodia S., and Berghold A. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years. Semin Thromb Hemost 23 (1997) 321-332
48. Balasa V.V. New anticoagulants: a pediatric perspective. Pediatr Blood Cancer (2005)
49. Weitz J.I., and Bates S.M. New anticoagulants. J Thromb Haemost 3 (2005) 1843-1853
50. Young G. Current and future antithrombotic agents in children. Expert Rev Cardiovasc Ther 2 (2004) 523-534
51. Andrew M., and Deveber G. Pediatric thromboembolism and stroke protocols (1997), B.C. Decker, Inc., Hamilton